For all equity investors recent years weeks have been a brutal experience: everybody is poorer compared to what they were at the start of the entire year.
Investors in Titan Medical Inc., a business that’s focused “on the design and development of a robotic surgical system for application in minimally invasive surgery,” have experienced the same pattern.
But with an added dimension: unbelievable volatility.
The shares are actually trading about half the amount these were trading at in the middle of last week with the main news being an overnight marketed offering of units (a $10.5-million deal that closed Friday); and the company telling the planet on Feb. 3 that, in the request of IIROC Market Surveillance, it “is not aware of any material undisclosed development at this time that will cause the recent movement in the Company’s share price.”
And some shareholders are angry. “As existing shareholders we have suffered the pain sensation from the company raising $10 million,” said one noting that Titan also raised two lots of equity last November, US$4 million via a private placement and $11.5 million using a public offering.